Bureaucrats, editor, reviewer, Administrators
5,246
edits
EVOLVE: Difference between revisions
Jump to navigation
Jump to search
usable
(fix references, verify additional sections) |
(usable) |
||
| Line 13: | Line 13: | ||
| fulltexturl=http://www.nejm.org/doi/full/10.1056/NEJMoa1205624 | | fulltexturl=http://www.nejm.org/doi/full/10.1056/NEJMoa1205624 | ||
| pdfurl=http://www.nejm.org/doi/pdf/10.1056/NEJMoa1205624 | | pdfurl=http://www.nejm.org/doi/pdf/10.1056/NEJMoa1205624 | ||
| status= | | status=Usable | ||
| subspecialty=Nephrology | | subspecialty=Nephrology | ||
| disease=Chronic Kidney Disease | | disease=Chronic Kidney Disease | ||
| Line 46: | Line 46: | ||
==Design== | ==Design== | ||
* Multicenter, multinational randomized control trial | * Multicenter, multinational randomized control trial<ref name="design"/><ref name="baseline"/> | ||
* N=3,883 patients with ESRD | * N=3,883 patients with ESRD | ||
** Cinacalcet (n=1,948) | ** Cinacalcet (n=1,948) | ||
| Line 54: | Line 54: | ||
* Primary outcome: Composite of death or CV event | * Primary outcome: Composite of death or CV event | ||
==Population | ==Population== | ||
===Inclusion Criteria=== | ===Inclusion Criteria=== | ||
* Age ≥18 years | * Age ≥18 years | ||
| Line 71: | Line 71: | ||
* Anticipated parathyroidectomy within 6 months after randomization | * Anticipated parathyroidectomy within 6 months after randomization | ||
===Baseline Characteristics | ===Baseline Characteristics=== | ||
''Significant differences were reported between mean diastolic BP and prior TIA rate.'' | ''Significant differences were reported between mean diastolic BP and prior TIA rate.'' | ||